Working Knowledge
Business Research for Business Leaders
COVID-19 Business Impact Center
Filter Results: (182) Arrow Down

HealthRemove Health →

New research on the health industry from Harvard Business School faculty on issues including improving practice, health care technology, and public policy.
Page 1 of 182 Results →

Hospital Allocation and Racial Disparities in Health Care

by Amitabh Chandra, Pragya Kakani, and Adam Sacarny

Black Americans experience disparities in health outcomes in the United States relative to other demographic groups. This study of heart attack sufferers over two decades develops a framework to examine the allocation of health care and the effectiveness of medical treatments, including beta-blockers and other technologies.

What Does December's Drug-Approval Dash Mean for COVID-19 Vaccines?

by Danielle Kost

Even in the best of times, pharmaceutical regulators tend to rush through drug applications in December. Now add in a ruthless pandemic. Research and insights from Lauren Cohen. Open for comment; Comment(s) posted.

Evaluating Innovative Health Care Solutions for Obesity

From Weight Watchers to bariatric surgery, innovations for combatting obesity abound. But which will do the most good for society and yield the best business results? Professor Regina Herzlinger discusses a new case study. Open for comment; Comment(s) posted.

The COVID Gender Gap: Why Fewer Women Are Dying

by Dina Gerdeman

To promote the greatest safety, public health officials should target their pandemic messaging to men differently than to women. Research by Vincent Pons and colleagues. Open for comment; Comment(s) posted.

What Can Economics Say About Alzheimer's Disease?

by Amitabh Chandra, Courtney Coile, and Corina Mommaerts

This essay discusses the role of market frictions and "missing medicines" in drug innovation and highlights how frameworks and toolkits of economists can help our understanding of the determinants and effects of Alzheimer's disease on health.

Many Small-Business Employees May Be Close to Losing Health Insurance

by Rachel Layne

Small-business owners have delayed rent payments and other bills to protect health benefits for employees. Now, financial pressure is mounting, according to research by Leemore Dafny, Yin Wei Soon, Zoë Cullen, and Christopher Stanton. Open for comment; Comment(s) posted.

Why American Health Care Needs Its Own SEC

by Regina E. Herzlinger

The United States needs a health care equivalent of the Securities and Exchange Commission to increase transparency and competition, argues Regina Herzlinger. Open for comment; Comment(s) posted.

Can Shared Service Delivery Increase Customer Engagement? A Study of Shared Medical Appointments

by Ryan W. Buell, Kamalini Ramdas, and Nazlı Sönmez

Shared service delivery means that customers are served in groups rather than individually. Results from a large-scale study of glaucoma follow-up appointments at a major eye hospital indicate that shared service delivery can significantly improve patients’ verbal and non-verbal engagement.

Is a Pandemic the Best Time To Try Out a New Idea?

Singapore's new nationwide, Bluetooth-based contact tracing program TraceTogether must overcome privacy issues to be effective. Would Singaporeans adopt TraceTogether? Professor Mitch Weiss discusses his new case study. Open for comment; Comment(s) posted.

COVID's Surprising Toll on Careers of Women Scientists

by Rachel Layne

Women scientists and those with young children are paying a steep career price in the pandemic, according to new research by Karim Lakhani, Kyle Myers, and colleagues. Open for comment; Comment(s) posted.

It's Time for a Bipartisan Health Plan for Employers and Employees

by Regina E. Herzlinger and Richard J. Boxer

Regina E. Herzlinger and Richard J. Boxer prescribe a seemingly impossible cure for battling health care options: a plan that embraces both Republican and Democratic ideas. Open for comment; Comment(s) posted.

Solving COVID'S Mental Health Crisis

by Howard Stevenson and Shirley Spence

COVID-19 affects more than physical health. Howard Stevenson and Shirley Spence describe how the pandemic is causing psychological trauma across a broad swath of society—and innovative methods to treat it. Open for comment; Comment(s) posted.

SmileDirect Looks Beyond Direct-to-Consumer Marketing

PODCAST: Teledentistry company SmileDirectClub is butting up against the limits of direct-to-consumer marketing. Len Schlesinger discusses his recent case study with Matt Higgins. Open for comment; Comment(s) posted.

COVID-19 and the Workplace: Implications, Issues, and Insights for Future Research and Action

by Ashley Whillans and 28 coauthors

Assembling a large, diverse team of researchers to make sense of COVID-19’s impact on issues of work and organizational psychology, this project explores changes that are unfolding for practitioners and human resources professionals.

Social Interactions in Pandemics: Fear, Altruism, and Reciprocity

by Laura Alfaro, Ester Faia, Nora Lamersdorf, and Farzad Saidi

An analysis of 89 cities worldwide shows that mobility responds to infection risk, altruism, and reciprocity. Correcting the SIR model to account for this behavior shows that a balanced approach involving stringency measures, in respect of human dignity, and responsible social preferences mitigates the pandemic health and economic costs.

A Mass Crisis Can Overwhelm Health Care. Liberia Found a Solution.

by Rachel Layne

Liberia trains community workers to help medical professionals on the front lines of disease control, says Brian Trelstad. Could the model work elsewhere? Open for comment; Comment(s) posted.

Paying It Backward and Forward: Expanding Access to Convalescent Plasma Therapy Through Market Design

by Scott Duke Kominers, Parag A. Pathak, Tayfun Sönmez, and M. Utku Ünver

Without a vaccine for COVID-19, the medical community has turned to a century-old therapy. This paper discusses a market design approach for expanding the collection and distribution of convalescent plasma.

In a Pandemic, What’s the Best Strategy for the Global Vaccine Alliance?

How should the vaccine alliance Gavi respond to the worldwide need for a cure for the COVID-19 pandemic? Tarun Khanna discusses his case study. Open for comment; Comment(s) posted.

HBS COVID-19 Global Policy Tracker

by Alberto Cavallo and Tannya Cai

The Harvard Business School Covid-19 Global Policy Tracker monitors new developments and changes in government policies throughout this crisis to analyze trends and correlations in countries' responses and economic impact.

Rebates in the Pharmaceutical Industry: Evidence from Medicines Sold in Retail Pharmacies in the U.S.

by Pragya Kakani, Michael Chernew, and Amitabh Chandra

Retail pharmacy data illustrates it can be misleading to use list prices instead of net prices to understand pharmaceutical prices. Analysts and economists working in public policy should be extremely cautious in drawing policy conclusions based on list prices alone.